Tryin
Trying on the underlying holdings of the ETFs in our protection universe at ETF Channel, we now have in contrast the buying and selling worth of every holding in opposition to the typical analyst 12-month ahead goal worth, and computed the weighted common implied analyst goal worth for the ETF itself. For the iShares S&P Mid-Cap 400 Worth ETF (Image: IJJ), we discovered that the implied analyst goal worth for the ETF primarily based upon its underlying holdings is $182.39 per unit.
With IJJ buying and selling at a latest worth close to $166.56 per unit, that implies that analysts see 9.50% upside for this ETF trying by to the typical analyst targets of the underlying holdings. Three of IJJ’s underlying holdings with notable upside to their analyst goal costs are Allscripts Healthcare Options, Inc. (Image: MDRX), Cantel Medical Corp (Image: CMD), and Avanos Medical Inc (Image: AVNS). Though MDRX has traded at a latest worth of $8.91/share, the typical analyst goal is 40.21% greater at $12.50/share. Equally, CMD has 36.87% upside from the latest share worth of $68.68 if the typical analyst goal worth of $94.00/share is reached, and analysts on common predict AVNS to…